NEUE C5A-BINDENDE NUCLEINSÄUREN

European patent · EP2802660 · In force

Register entry

Publication number
EP2802660
Application number
EP13700617
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 10, 2013
Published
Nov 19, 2014
Granted
Feb 19, 2020
Protection ends at the latest
Jan 9, 2033
Next annual fee due
Jan 31, 2027
IPC classes
C12N 15/115 (2010.01)
A61K 31/7088 (2006.01)
A61P 29/00 (2006.01)
Priority
EP 12000106 10.01.2012
WO PCT/EP2012/000089 10.01.2012
EP 12006960 08.10.2012
PCT application
PCT/EP2013/000056 10.01.2013
PCT publication
WO2013/104540 18.07.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Apr 7, 2020

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 07.04.2020

  6. Feb 19, 2020

    Granted

    Published in Swissreg on 19.02.2020

Parties

Holder

APTARION biotech AG

Max-Dohrn-Straße 8-10, 10589 Berlin, DE

Agent

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventor

VATER, Axel

13467 Berlin, DE

KLUSSMANN, Sven

10585 Berlin, DE

BUCHNER, Klaus

14197 Berlin, DE

HÖHLIG, Kai

10317 Berlin, DE

MAASCH, Christian

13509 Berlin, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.